Author

Brian P. Tullius

Observed names: B.P. Tullius, Brian P Tullius, Brian Tullius

Institution: AdventHealth for Children

Observed institutions: Nationwide Children's Hospital, AdventHealth Orlando, AdventHealth for Children, University of California Davis Medical Center, UC Davis Health, Abigail Wexner Research Institute, The Ohio State University

ORCID: 0000-0003-0481-7627

Observed ORCID: 0000-0003-0481-7627

OpenAlex ID: A5007961611

COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients

2021 · Jennifer A. Belsky, Brian P. Tullius, et al. · Journal of Infection · 241

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future

2021 · Margaret G. Lamb, Hemalatha G. Rangarajan, et al. · Stem Cell Research & Therapy · 86

Hospital-to-Home Interventions, Use, and Satisfaction: A Meta-analysis

2018 · Michelle Y. Hamline, Rebecca L. Speier, et al. · PEDIATRICS · 58

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

2022 · Ezgi Elmas, Noushin Saljoughian, et al. · Frontiers in Oncology · 48

Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies

2023 · Md Faqrul Hasan, Amanda R Campbell, et al. · Journal for ImmunoTherapy of Cancer · 44

Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity

2020 · Meisam Naeimi Kararoudi, Brian P. Tullius, et al. · Seminars in Hematology · 23

Natural Killer Cell Immunotherapy for Osteosarcoma

2020 · Brian P. Tullius, Buhvana A. Setty, et al. · Advances in experimental medicine and biology · 23

The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH

2017 · B.P. Tullius, U. Athale, et al. · Journal of Thrombosis and Haemostasis · 23

Natural killer cells for antiviral therapy

2023 · Davey M. Smith, Jolie R. Schafer, et al. · Science Translational Medicine · 22

Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite

2020 · Ajay Gupta, Cenny Taslim, et al. · Cancer Drug Resistance · 14

Novel heterozygous mutation in the PTEN gene associated with ovarian germ cell tumor complicated by growing teratoma syndrome and overgrowth in a two‐year‐old female

2019 · Brian P. Tullius, Suma P. Shankar, et al. · Pediatric Blood & Cancer · 11

Haploidentical Hematopoietic Stem Cell Transplant for Patients with Sickle Cell Disease Using Thiotepa, Fludarabine, Thymoglobulin, Low Dose Cyclophosphamide, 200 Cgy TBI and Post-Transplant Cyclophosphamide.

2024 · Susan Kelly, Jennifer Domm, et al. · Transplantation and Cellular Therapy · 1

Abstract 151: Combination of cytokines, PM21-particle stimulation, and TGF-β conditioning results in Natural Killer cells with enhanced cytotoxicity and infiltration of solid tumors.

2026 · Jeremiah L. Oyer, Tayler J. Croom-Perez, et al. · Cancer Research

993 Knockout of DNAM-1 competing inhibitory receptors enhances natural killer cell anti-tumor functions against neuroblastoma

2023 · Tayler J Croom-Perez, Liza D Robles-Carrillo, et al. · Journal for ImmunoTherapy of Cancer

Abstract 2909: Genetically engineered Natural Killer cells as an immunotherapeutic approach for the treatment of neuroblastoma

2023 · Tayler J. Croom-Perez, Jeremiah L. Oyer, et al. · Cancer Research

Works count: 15

Citation count: 594

H-index: 11

I10-index: 11